SCHEMBL2809514

SCHEMBL2809514

COc1ccc(CN2CCc3nn(C)c4nc(N5CCN(C)CC5)nc2c34)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.46
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
HRH4 Q9H3N8 5/20 0.41
ALDH1A1 P00352 5/20 0.41
USP2 O75604 4/20 0.41
CASP1 P29466 3/20 0.41
CASP7 P55210 3/20 0.41
HIF1A Q16665 3/20 0.41
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 3/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
PTBP1 P26599 1/20 0.41
HRH1 P35367 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.39
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811678 0.92 CCNE2 (0.39) HTR6CCNE1CDK2ALDH1A1HPGD
SCHEMBL2812071 0.90 SMN1; SMN2 (0.43) ALDH1A1HPGDKDM4ETSHRL3MBTL1
SCHEMBL2809527 0.90 MAPT (0.45) ALDH1A1USP2CASP1CASP7CYP1A2
SCHEMBL2810400 0.89 CFTR (0.46) HTR6ALDH1A1USP2HPGDKDM4E
SCHEMBL2810425 0.89 SMN1; SMN2 (0.44) ALDH1A1CASP1KDM4ETSHRHTR2C
SCHEMBL2815919 0.88 TSHR (0.43) ALDH1A1KDM4ETSHRMEN1KMT2A
SCHEMBL13145459 0.88 NPC1 (0.39) HTR6HRH4ALDH1A1HPGDKDM4E
SCHEMBL2814404 0.88 HRH4 (0.44) HTR6CCNE1CDK2HRH4ALDH1A1
SCHEMBL2809446 0.86 TSHR (0.38) HTR6CCNE1CDK2ALDH1A1USP2
SCHEMBL13131680 0.84 ADORA3 (0.40) ALDH1A1KDM4EGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 HTR6 1986/4885CCNE1 196/4885CDK2 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.